Efficacy and safety of lopinavir-ritonavir in COVID-19: A systematic review of randomized controlled trials

• Päätekijät: Tejas K. Patel (Tekijä), Parvati B. Patel (Tekijä), Manish Barvaliya (Tekijä), Manoj Kumar Saurabh (Tekijä), Hira Lal Bhalla (Tekijä), Prem Parkash Khosla (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Elsevier, 2021-06-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Background: Lopinavir-ritonavir is a repurposed drug for coronavirus disease-2019 (COVID-19). In this study, a pooled effect of lopinavir-ritonavir on mortality, virological cure, radiological improvement and safety profile in COVID-19 patients has been evaluated. Methods: The databases were searche...